In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential based on recent research conducted by ZS on the top 25 pharma companies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: David Jackson
All content for Inside Global Pharma is the property of ZS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential based on recent research conducted by ZS on the top 25 pharma companies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: David Jackson
What next in Oncology – Defining business strategy in an uncertain future
Inside Global Pharma
22 minutes 2 seconds
5 years ago
What next in Oncology – Defining business strategy in an uncertain future
COVID-19 has pushed the idea of scenario planning to the forefront. It is becoming increasingly important to be able to anticipate and plan for the unexpected by looking at the extremes, and how they could change the business. In this episode we focus on oncology and discuss three different worlds that could emerge in the future and implications on pharma’s business strategy.
Hosted by: Matilda Males
Produced by: Matilda Males
Featuring: Jennifer Curtis and Malik Kaman
Inside Global Pharma
In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential based on recent research conducted by ZS on the top 25 pharma companies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: David Jackson
